OPTN gene therapy increases autophagy and protects mitochondria in SOD1 ‐G93A‐expressing transgenic mice and cells

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by progressive motor neuron (MN) death. Mutation of the superoxide dismutase 1 (SOD1) gene, which results in abnormal protein aggregation, is one of the causes of familial ALS. Autophagic dysfunction occurs in SOD1-G93A mutant mice as the disease progresses, but the etiology of this disease is still unclear. Optineurin (OPTN) is an...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyotrophic Lateral Sclerosis Research
• Share to Autophagy in Disease and Therapy
• Share to Parkinson's Disease Mechanisms and Treatments